Literature DB >> 3514459

Induction of protective immunity to monoclonal-antibody-defined Plasmodium falciparum antigens requires strong adjuvant in Aotus monkeys.

W A Siddiqui, L Q Tam, S C Kan, K J Kramer, S E Case, K L Palmer, K M Yamaga, G S Hui.   

Abstract

Monoclonal antibodies to the major Plasmodium falciparum merozoite surface coat and rhoptry antigens were produced. A combination of the affinity-purified polypeptides with Freund complete adjuvant which was given three times completely protected an Aotus lemurinus azure (karotype VI) monkey against homologous challenge; however, immunization with the same polypeptides with a muramyl dipeptide derivative [MDP-Lys(L18)] did not protect a second Aotus monkey, even though comparable high antibody titers were induced.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3514459      PMCID： PMC262236          DOI： 10.1128/iai.52.1.314-318.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  32 in total

1.  A one-step purification of membrane proteins using a high efficiency immunomatrix.

Authors:  C Schneider; R A Newman; D R Sutherland; U Asser; M F Greaves
Journal:  J Biol Chem       Date:  1982-09-25       Impact factor: 5.157

2.  A large-scale in vitro production system for Plasmodium falciparum.

Authors:  K L Palmer; G S Hui; W A Siddiqui; E L Palmer
Journal:  J Parasitol       Date:  1982-12       Impact factor: 1.276

3.  Use of a synthetic adjuvant in an effective vaccination of monkeys against malaria.

Authors:  W A Siddiqui; S C Kan; K Kramer; S Case; K Palmer; J F Niblack
Journal:  Nature       Date:  1981-01-01       Impact factor: 49.962

4.  Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.

Authors:  W A Siddiqui; D W Taylor; S C Kan; K Kramer; S M Richmond-Crum; S Kotani; T Shiba; S Kusumoto
Journal:  Science       Date:  1978-09-29       Impact factor: 47.728

5.  Immunization against malaria with antigen from Plasmodium falciparum cultivated in vitro.

Authors:  R T Reese; W Trager; J B Jensen; D A Miller; R Tantravahi
Journal:  Proc Natl Acad Sci U S A       Date:  1978-11       Impact factor: 11.205

6.  Immunization of experimental monkeys against Plasmodium falciparum: use of synthetic adjuvants.

Authors:  W A Siddiqui; D W Taylor; S C Kan; K Kramer; S M Richmond-Crum; S Kotani; T Shiba; S Kasumoto
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

7.  Inhibition of P. falciparum growth in human erythrocytes by monoclonal antibodies.

Authors:  L H Perrin; E Ramirez; P H Lambert; P A Miescher
Journal:  Nature       Date:  1981-01-22       Impact factor: 49.962

8.  Primary structure of the precursor to the three major surface antigens of Plasmodium falciparum merozoites.

Authors:  A A Holder; M J Lockyer; K G Odink; J S Sandhu; V Riveros-Moreno; S C Nicholls; Y Hillman; L S Davey; M L Tizard; R T Schwarz
Journal:  Nature       Date:  1985 Sep 19-25       Impact factor: 49.962

9.  Merozoite vaccination of douroucouli monkeys against falciparum malaria.

Authors:  G H Mitchell; W H Richards; G A Butcher; S Cohen
Journal:  Lancet       Date:  1977-06-25       Impact factor: 79.321

10.  Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody.

Authors:  A A Holder; R R Freeman
Journal:  J Exp Med       Date:  1982-11-01       Impact factor: 14.307
View more
  19 in total

1.  Rhoptry-associated protein 1-binding monoclonal antibody raised against a heterologous peptide sequence inhibits Plasmodium falciparum growth in vitro.

Authors:  R Moreno; F Pöltl-Frank; D Stüber; H Matile; M Mutz; N A Weiss; G Pluschke
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  In vivo expression and immunological studies of the 42-kilodalton carboxyl-terminal processing fragment of Plasmodium falciparum merozoite surface protein 1 in the baculovirus-silkworm system.

Authors:  Alan L Y Pang; Caryn N Hashimoto; Leslie Q Tam; Z Q Meng; George S N Hui; Walter K K Ho
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

3.  Adjuvant formulations possess differing efficacy in the potentiation of antibody and cell mediated responses to a human malaria vaccine under selective immune genes knockout environment.

Authors:  George S Hui; Caryn N Hashimoto
Journal:  Int Immunopharmacol       Date:  2008-04-03       Impact factor: 4.932

4.  Identification of Babesia bovis merozoite surface antigens by using immune bovine sera and monoclonal antibodies.

Authors:  W L Goff; W C Davis; G H Palmer; T F McElwain; W C Johnson; J F Bailey; T C McGuire
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

5.  Evaluation of three Pichia pastoris-expressed Plasmodium falciparum merozoite proteins as a combination vaccine against infection with blood-stage parasites.

Authors:  Dongmei Zhang; Weiqing Pan
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

6.  Localisation of internal antigens of Plasmodium falciparum using monoclonal antibodies and colloidal gold.

Authors:  L T Ingram; D J Stenzel; U A Kara; G R Bushell
Journal:  Parasitol Res       Date:  1988       Impact factor: 2.289

7.  Generalized immunological recognition of the major merozoite surface antigen (gp195) of Plasmodium falciparum.

Authors:  S P Chang; G S Hui; A Kato; W A Siddiqui
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

8.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

9.  Merozoite surface coat precursor protein completely protects Aotus monkeys against Plasmodium falciparum malaria.

Authors:  W A Siddiqui; L Q Tam; K J Kramer; G S Hui; S E Case; K M Yamaga; S P Chang; E B Chan; S C Kan
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

10.  Effect of GPI anchor moiety on the immunogenicity of DNA plasmids encoding the 19-kDa C-terminal portion of Plasmodium falciparum MSP-1.

Authors:  G Li; S H Basagoudanavar; D C Gowda
Journal:  Parasite Immunol       Date:  2008-04-14       Impact factor: 2.280
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.